All In Biotech

Drug Trial Radar · NCT07746687

A Study of JNJ-95597528 in Participants With Inadequately Controlled Moderate to Severe Asthma

A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-controlled, Dose-ranging Trial to Evaluate the Efficacy and Safety of JNJ-95597528 for the Treatment of Adult Participants With Inadequately Controlled Moderate to Severe Asthma

Last checked: Nov 20, 2026Latest source record: Nov 3, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingRandomized with 440 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

440

Planned (sponsor's estimate)

Start

Oct 5, 2026

Primary completion

Sep 11, 2029

Study completion Jul 1, 2030

Sponsor

Lead sponsor
Janssen Research & Development, LLCJohnson & Johnson (Janssen) (JNJ)
Sponsor type
Industry
First posted
Aug 5, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 85 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to assess how well JNJ-95597528 works when compared to placebo in adult participants with moderate to severe asthma (long-term condition that affects the airways in your lungs).

Conditions

  • Asthma

Interventions

  • JNJ-95597528Drug

    JNJ-95597528 will be administered as subcutaneous (SC) injection.

  • PlaceboDrug

    Placebo will be administered as SC injection.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of Asthma Exacerbations Through Week 48Time frame: Up to Week 48

Locations

19 sites in 5 countries. Site status is shown where the registry gives one.

  • Allianz Research Institute, Inc.

    Westminster, California · Recruiting

  • Boston Specialists

    Boston, Massachusetts · Recruiting

  • Clinical Research Institute

    Minneapolis, Minnesota · Recruiting

  • Midwest Clinical Research LLC

    St Louis, Missouri · Recruiting

  • Equity Medical

    The Bronx, New York · Recruiting

  • OK Clinical Research

    Edmond, Oklahoma · Recruiting

  • Allergy Asthma and Clinical Research Center Martha Tarpay MD

    Oklahoma, Texas · Recruiting

  • INAER - Investigacion en Alergias y Enfermedades Respiratorias

    Buenos Aires, Argentina · Recruiting

  • Instituto de Medicina Respiratoria IMER

    Córdoba, Argentina · Recruiting

  • Fundacion Scherbovsky

    Mendoza, Argentina · Recruiting

  • Instituto De Especialidades De La Salud SRL

    Rosario, Argentina · Recruiting

  • IBAMEDICA Propiedad de IBA Santa Fe S.A.S

    Santa Fe, Argentina · Recruiting

  • China Japan Friendship Hospital

    Beijing, China · Recruiting

  • Changzhou No 2 Peoples Hospital

    Changzhou, China · Recruiting

  • Ningbo medical center lihuili hospital

    Ningbo, China · Recruiting

  • Shanxi Bethune Hospital

    Taiyuan, China · Recruiting

  • Tel Aviv Sourasky Medical Center

    Tel Aviv, Israel · Recruiting

  • Idaimae Minami4jo Internal Medicine

    Sapporo, Japan · Recruiting

  • Tokyo Shinagawa Hospital

    Shinagawa City, Japan · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.